103 related articles for article (PubMed ID: 9399942)
1. Preferential localization of systemically administered radiolabeled interleukin 1alpha in experimental inflammation in mice by binding to the type II receptor.
van der Laken CJ; Boerman OC; Oyen WJ; van de Ven MT; Chizzonite R; Corstens FH; van der Meer JW
J Clin Invest; 1997 Dec; 100(12):2970-6. PubMed ID: 9399942
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response.
Oldenburg HS; Pruitt JH; Lazarus DD; Rogy MA; Chizzonite R; Lowry SF; Moldawer LL
Cytokine; 1995 Aug; 7(6):510-6. PubMed ID: 8580366
[TBL] [Abstract][Full Text] [Related]
3. In vivo expression of interleukin-1 receptors during various experimentally induced inflammatory conditions.
van der Laken CJ; Boerman OC; Oyen WJ; Laverman P; van de Ven MT; Corstens FH; van der Meer JW
J Infect Dis; 1998 May; 177(5):1398-401. PubMed ID: 9593033
[TBL] [Abstract][Full Text] [Related]
4. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells.
Chen CJ; Kono H; Golenbock D; Reed G; Akira S; Rock KL
Nat Med; 2007 Jul; 13(7):851-6. PubMed ID: 17572686
[TBL] [Abstract][Full Text] [Related]
5. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice.
Labow M; Shuster D; Zetterstrom M; Nunes P; Terry R; Cullinan EB; Bartfai T; Solorzano C; Moldawer LL; Chizzonite R; McIntyre KW
J Immunol; 1997 Sep; 159(5):2452-61. PubMed ID: 9278338
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of type 1 interleukin-1 receptor extracellular-domain complementary DNA into rabbit synovial cell line HIG-82 results in cellular blockade of interleukin-1 signal transduction.
Mehraban F; Kasturi S
Arthritis Rheum; 1998 Mar; 41(3):515-24. PubMed ID: 9506580
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1-mediated febrile responses in mice and interleukin-1 beta activation of NFkappaB in mouse primary astrocytes, involves the interleukin-1 receptor accessory protein.
Zetterström M; Lundkvist J; Malinowsky D; Eriksson G; Bartfai T
Eur Cytokine Netw; 1998 Jun; 9(2):131-8. PubMed ID: 9681388
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury.
Furuichi K; Wada T; Iwata Y; Kokubo S; Hara A; Yamahana J; Sugaya T; Iwakura Y; Matsushima K; Asano M; Yokoyama H; Kaneko S
Crit Care Med; 2006 Sep; 34(9):2447-55. PubMed ID: 16849996
[TBL] [Abstract][Full Text] [Related]
9. Possible role of interleukin-1 in the regulation of bovine corpus luteum throughout the luteal phase.
Nishimura R; Bowolaksono A; Acosta TJ; Murakami S; Piotrowska K; Skarzynski DJ; Okuda K
Biol Reprod; 2004 Nov; 71(5):1688-93. PubMed ID: 15253926
[TBL] [Abstract][Full Text] [Related]
10. IL-1 receptor accessory protein is an essential component of the IL-1 receptor.
Cullinan EB; Kwee L; Nunes P; Shuster DJ; Ju G; McIntyre KW; Chizzonite RA; Labow MA
J Immunol; 1998 Nov; 161(10):5614-20. PubMed ID: 9820540
[TBL] [Abstract][Full Text] [Related]
11. Intracellular IL-1alpha-binding proteins contribute to biological functions of endogenous IL-1alpha in systemic sclerosis fibroblasts.
Kawaguchi Y; Nishimagi E; Tochimoto A; Kawamoto M; Katsumata Y; Soejima M; Kanno T; Kamatani N; Hara M
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14501-6. PubMed ID: 16971486
[TBL] [Abstract][Full Text] [Related]
12. Induction of IL-1, in the testes of adult mice, following subcutaneous administration of turpentine.
Elhija MA; Lunenfeld E; Huleihel M
Am J Reprod Immunol; 2006 Feb; 55(2):136-44. PubMed ID: 16433833
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1alpha up-regulation in vivo by a potent carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) and control of DMBA-induced inflammatory responses.
Li X; Eckard J; Shah R; Malluck C; Frenkel K
Cancer Res; 2002 Jan; 62(2):417-23. PubMed ID: 11809690
[TBL] [Abstract][Full Text] [Related]
14. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis.
Bessis N; Guéry L; Mantovani A; Vecchi A; Sims JE; Fradelizi D; Boissier MC
Eur J Immunol; 2000 Mar; 30(3):867-75. PubMed ID: 10741403
[TBL] [Abstract][Full Text] [Related]
15. Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infection.
van der Laken CJ; Boerman OC; Oyen WJ; van de Ven MT; Claessens RA; van der Meer JW; Corstens FH
Eur J Nucl Med; 1996 Nov; 23(11):1531-5. PubMed ID: 8854854
[TBL] [Abstract][Full Text] [Related]
16. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
Pantschenko AG; Pushkar I; Anderson KH; Wang Y; Miller LJ; Kurtzman SH; Barrows G; Kreutzer DL
Int J Oncol; 2003 Aug; 23(2):269-84. PubMed ID: 12851675
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
[TBL] [Abstract][Full Text] [Related]
18. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
19. Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
Spohn G; Keller I; Beck M; Grest P; Jennings GT; Bachmann MF
Eur J Immunol; 2008 Mar; 38(3):877-87. PubMed ID: 18253928
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation.
Docagne F; Campbell SJ; Bristow AF; Poole S; Vigues S; Guaza C; Perry VH; Anthony DC
Eur J Neurosci; 2005 Mar; 21(5):1205-14. PubMed ID: 15813930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
